Search Results1-11 of  11

  • 秋永 士朗 ID: 9000004417642

    Articles in CiNii:3

    • 新規抗癌抗生物質GE3のE2F転写因子阻害活性 (1996)
    • 抗癌剤研究開発におけるゲノム創薬と分子標的治療の動き (特集 癌分子治療とゲノム) (2002)
    • 新規抗癌抗生物質GE3の単離、構造及び生物活性 : 有機化学・天然物化学 (1996)
  • 秋永 士朗 ID: 9000004687508

    協和発酵・研 (1993 from CiNii)

    Articles in CiNii:2

    • P-191 選択的Protein Kinase C(PKC)阻害剤UCNー01の細胞周期に及ぼす効果 (1993)
    • P-192 Protein Kinase C(PKC)選択的阻害剤UCNー01のin vitro及びin vivoにおける各種ヒト肺がん株に対する抗腫瘍効果 (1993)
  • 秋永 士朗 ID: 9000009568713

    Articles in CiNii:2

    • 創薬の新しい展開 (1999)
    • 基礎 Kinase阻害薬臨床開発の課題と問題点--日本発kinase阻害薬UCN-01の経験を踏まえて (2009)
  • 秋永 士朗 ID: 9000010735565

    Articles in CiNii:2

    • c-met inhibitor (XL880, ARQ197) (2009)
    • A Japanese pharmaceutical company view for entry into First-in-Human (FIH) study : is there any issue to start FIH study in Japan regarding to the regulation and the clinical sites? (2012)
  • 秋永 士朗 ID: 9000241536846

    Articles in CiNii:1

    • Clinical application of mogamulizumab, a humanized anti-CCR4 antibody, for T-cell lymphoma (2013)
  • 秋永 士朗 ID: 9000327084648

    Articles in CiNii:1

    • An example for the successful drug discovery from open innovation : from a corporate view (2016)
  • 秋永 士朗 ID: 9000403025112

    Articles in CiNii:1

    • Development of mRNA Therapeutics (2019)
  • 秋永 士朗 ID: 9000403406693

    Articles in CiNii:1

    • Quality and Non-clinical Safety Evaluation for mRNA Therapeutics (2019)
  • AKINAGA Shiro ID: 9000014129962

    Articles in CiNii:5

    • A new therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449 : strategy and comparison with other kinase inhibitors (2008)
    • FLT3 tyrosine kinase inhibitors : current status and future perspectives for their development (2008)
    • 基礎 Mechanism based drug screening (2001)
  • AKINAGA Shiro ID: 9000258043633

    協和発酵工業株式会社 臨床開発部 (2008 from CiNii)

    Articles in CiNii:1

    • A new therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors (2008)
  • AKINAGA Shiro ID: 9000347129449

    協和発酵キリン(株)研究開発本部フェロー (2015 from CiNii)

    Articles in CiNii:1

    • 日本発First-in-class抗体モガムリズマブの創製 (2015)
Page Top